These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27981260)

  • 21. A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
    McClay EF; Bogart J; Herndon JE; Watson D; Evans L; Seagren SL; Green MR;
    Am J Clin Oncol; 2005 Feb; 28(1):81-90. PubMed ID: 15685040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
    Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.
    Simone CB; Bogart JA; Cabrera AR; Daly ME; DeNunzio NJ; Detterbeck F; Faivre-Finn C; Gatschet N; Gore E; Jabbour SK; Kruser TJ; Schneider BJ; Slotman B; Turrisi A; Wu AJ; Zeng J; Rosenzweig KE
    Pract Radiat Oncol; 2020; 10(3):158-173. PubMed ID: 32222430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre.
    Yan M; Toh TS; Lindsay PE; Weiss J; Hueniken K; Yeung C; Sugumar V; Pinto D; Tadic T; Sun A; Bezjak A; Cho J; Raman S; Giuliani M; Moraes FY; Liu G; Hope AJ; Lok BH
    Clin Transl Radiat Oncol; 2021 Sep; 30():43-49. PubMed ID: 34296000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor.
    Zhao J; Zhang W; Er P; Chen X; Guan Y; Qian D; Wang J; Yuan Z; Zhao L; Wang P; Pang Q
    J Cancer; 2020; 11(17):4957-4964. PubMed ID: 32742443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential chemotherapy followed by radical thoracic radiotherapy (50 Gy in 25 fractions) in limited stage small cell lung cancer.
    Iqbal MS; Carlow J; McDonald F; Atherton P; Turnbull H; Singhal S; Simmons T; Mulvenna P; Kovarik J; McMenemin R; Gardiner J; Greystoke A
    Ecancermedicalscience; 2020; 14():1019. PubMed ID: 32256702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer.
    Sama S; Kerrigan K; Sinnott JA; Puri S; Akerley W; Haaland B; Patel S
    Cancer Treat Res Commun; 2023; 35():100686. PubMed ID: 36736060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
    Stinchcombe TE; Fan W; Schild SE; Vokes EE; Bogart J; Le QT; Thomas CR; Edelman MJ; Horn L; Komaki R; Cohen HJ; Kishor Ganti A; Pang H; Wang X
    Cancer; 2019 Feb; 125(3):382-390. PubMed ID: 30343497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer.
    Bettington CS; Tripcony L; Bryant G; Hickey B; Pratt G; Fay M
    J Med Imaging Radiat Oncol; 2013 Feb; 57(1):105-12. PubMed ID: 23374562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
    Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
    J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer.
    Park J; Kang MK
    Radiat Oncol J; 2018 Mar; 36(1):35-44. PubMed ID: 29621871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative.
    Allen SG; Dragovic AF; Yin HM; Bryant AK; Paximadis PA; Matuszak MM; Schipper MJ; Dess RT; Hayman JA; Dominello MM; Kestin LL; Movsas B; Jolly S; Bergsma DP;
    Pract Radiat Oncol; 2023; 13(5):444-453. PubMed ID: 37100388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
    Schild SE; Bonner JA; Shanahan TG; Brooks BJ; Marks RS; Geyer SM; Hillman SL; Farr GH; Tazelaar HD; Krook JE; Geoffroy FJ; Salim M; Arusell RM; Mailliard JA; Schaefer PL; Jett JR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):943-51. PubMed ID: 15234027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of treatment and care practices in small-cell lung cancer among German radiation oncologists.
    Gnüchtel J; Vordermark D; Medenwald D
    Strahlenther Onkol; 2023 Jul; 199(7):631-644. PubMed ID: 36418442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of high‑risk factors for brain metastasis and prognosis after prophylactic cranial irradiation in limited‑stage small cell lung cancer.
    Yu G; Zhou J; Dai J; Lian R
    Oncol Lett; 2024 Sep; 28(3):422. PubMed ID: 39035048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
    Fried DB; Morris DE; Poole C; Rosenman JG; Halle JS; Detterbeck FC; Hensing TA; Socinski MA
    J Clin Oncol; 2004 Dec; 22(23):4837-45. PubMed ID: 15570087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Thoracic Radiation Therapy Dosing in the Treatment of Limited-Stage Small Cell Lung Cancer: A Study Based on the National Cancer Database.
    Shidal C; Osmundson EC; Cui Y; Yoon HS; Bailey CE; Cai Q; Shu XO
    Adv Radiat Oncol; 2022; 7(5):100907. PubMed ID: 35469183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
    Clin Lung Cancer; 2018 Jul; 19(4):371-376. PubMed ID: 29559208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.